
doi: 10.1002/dta.1918
pmid: 26593301
The possibility of the detection of olodaterol and vilanterol, two novel β2‐agonists, in human urine for the purpose of sport drug testing was investigated. Compounds of interest were analyzed by liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) employing methods commonly used in the World Anti‐Doping Agency (WADA) accredited laboratories. For both substances, the respective parent compound was found to be a suitable target analyte for monitoring therapeutic dose administration. Copyright © 2015 John Wiley & Sons, Ltd.
Doping in Sports, Male, Reproducibility of Results, Performance-Enhancing Substances, Middle Aged, Urinalysis, Chlorobenzenes, Benzoxazines, Substance Abuse Detection, Predictive Value of Tests, Tandem Mass Spectrometry, Administration, Inhalation, Humans, Adrenergic beta-2 Receptor Agonists, Benzyl Alcohols, Chromatography, Liquid
Doping in Sports, Male, Reproducibility of Results, Performance-Enhancing Substances, Middle Aged, Urinalysis, Chlorobenzenes, Benzoxazines, Substance Abuse Detection, Predictive Value of Tests, Tandem Mass Spectrometry, Administration, Inhalation, Humans, Adrenergic beta-2 Receptor Agonists, Benzyl Alcohols, Chromatography, Liquid
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
